• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠腹膜巨噬细胞上血管活性肠肽(VIP)受体的同源调节

Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.

作者信息

Pozo D, Guerrero J M, Calvo J R

机构信息

Department of Medical Biochemistry and Molecular Biology, University of Seville School of Medicine, Spain.

出版信息

Peptides. 1995;16(2):313-8. doi: 10.1016/0196-9781(94)00192-8.

DOI:10.1016/0196-9781(94)00192-8
PMID:7784261
Abstract

In the present study, we examined the effect of pretreatment with VIP and various peptides structurally related to VIP such us PHI, helodermin, and secretin on VIP receptor number and affinity, as well as VIP-stimulated cyclic AMP production in rat peritoneal macrophages. Short-term (5-30 min) exposures of rat peritoneal macrophages to 0.1 microM VIP induced a rapid reduction in specific binding. Pretreatment for 15 and 30 min caused 26% (SEM = 6) and 48% (SEM = 4) reduction in specific binding, respectively. The maximal effect was observed at 120 min, causing a decrease of 67% (SEM = 6) in specific binding. Pretreatment with 0.1 microM VIP for 15, 30, and 120 min caused 23% (SEM = 9), 52% (SEM = 4), and 76% (SEM = 4) reduction in cyclic AMP production, respectively. Only VIP concentrations at the nanomolar level and higher were shown to be effective. The potency of VIP and related peptides to desensitize was similar to their potency to occupy receptors and to activate cyclic AMP production. The internalization of radioiodinated VIP was also studied. It was shown that receptor-bound ligand is internalized during the downregulation process. However, the diminution in VIP binding to macrophages was not completely explained by internalization.

摘要

在本研究中,我们检测了用血管活性肠肽(VIP)以及与VIP结构相关的各种肽(如胰高血糖素样肽I、胃泌素释放肽、促胰液素)预处理对大鼠腹腔巨噬细胞中VIP受体数量、亲和力以及VIP刺激的环磷酸腺苷(cAMP)生成的影响。将大鼠腹腔巨噬细胞短期(5 - 30分钟)暴露于0.1微摩尔/升的VIP会导致特异性结合迅速减少。预处理15分钟和30分钟分别使特异性结合减少26%(标准误 = 6)和48%(标准误 = 4)。在120分钟时观察到最大效应,特异性结合减少了67%(标准误 = 6)。用0.1微摩尔/升的VIP预处理15分钟、30分钟和120分钟分别使cAMP生成减少23%(标准误 = 9)、52%(标准误 = 4)和76%(标准误 = 4)。只有纳摩尔及更高浓度的VIP才显示出有效。VIP及相关肽脱敏的效力与其占据受体和激活cAMP生成的效力相似。还研究了放射性碘化VIP的内化情况。结果表明,在下调过程中受体结合的配体发生内化。然而,巨噬细胞上VIP结合的减少并不能完全用内化来解释。

相似文献

1
Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.大鼠腹膜巨噬细胞上血管活性肠肽(VIP)受体的同源调节
Peptides. 1995;16(2):313-8. doi: 10.1016/0196-9781(94)00192-8.
2
Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.火鸡大脑皮层中血管活性肠肽和垂体腺苷酸环化酶激活多肽的受体:通过[125I]-血管活性肠肽结合进行表征及其对环磷酸腺苷合成的影响
Gen Comp Endocrinol. 2004 Jun;137(2):187-95. doi: 10.1016/j.ygcen.2004.03.007.
3
Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
Regul Pept. 1992 Feb 18;37(3):195-203. doi: 10.1016/0167-0115(92)90614-z.
4
Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.血管活性肠肽受体在小鼠腹腔巨噬细胞中的表达:功能与分子特征
J Neuroimmunol. 1994 Feb;50(1):85-93. doi: 10.1016/0165-5728(94)90218-6.
5
Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.大鼠肺泡巨噬细胞上血管活性肠肽受体的特性研究
Am J Physiol. 1994 Sep;267(3 Pt 1):L256-62. doi: 10.1152/ajplung.1994.267.3.L256.
6
Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices.垂体腺苷酸环化酶激活肽、血管活性肠肽及相关肽对大鼠神经元和星形胶质细胞培养物及大脑皮质切片中环磷酸腺苷形成的影响。
Pharmacol Rep. 2007 Jul-Aug;59(4):414-20.
7
Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.大鼠和小鼠腹膜巨噬细胞中血管活性肠肽受体-效应器系统拮抗剂的特性研究
Eur J Pharmacol. 1997 Mar 5;321(3):379-86. doi: 10.1016/s0014-2999(96)00966-1.
8
Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.大鼠腹膜巨噬细胞中血管活性肠肽(VIP)功能性受体的特性研究
Regul Pept. 1991 Apr 25;33(2):133-43. doi: 10.1016/0167-0115(91)90208-x.
9
Characterization of VIP-and helodermin-preferring receptors on rat platelets.
Regul Pept. 1996 Jul 5;63(2-3):99-103. doi: 10.1016/0167-0115(96)00026-2.
10
Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells.胸腺肽α1与大鼠和小鼠免疫活性细胞中的血管活性肠肽(VIP)受体 - 效应系统相互作用。
Immunopharmacology. 1996 Sep;34(2-3):113-23. doi: 10.1016/0162-3109(96)00131-2.